Skip to Main Content

Paper Details

Lecanamab Ushers in a New Era of Anti-Amyloid Therapy for Alzheimer's Disease.
Ann Neurol
3
2023
Alzheimer's Disease, Lecanamab
Author NameAffiliation
Eric McDadeHope Center for Neurological Disorders, and Knight Alzheimer Disease Research Center, Washington University in St. Louis School of Medicine
David M HoltzmanHope Center for Neurological Disorders, and Knight Alzheimer Disease Research Center, Washington University in St. Louis School of Medicine
  • 1 - 2

Datasets

Release 1.2